Valuation (67%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 19.87 | N/A |
| PEG Ratio (TTM) | 3.62 | N/A |
| P/S Ratio (TTM) | 1.79 | N/A |
| P/B Ratio (TTM) | 5.36 | N/A |
| P/FCF Ratio (TTM) | 17.61 | N/A |
| Price to 5YR AVG Earnings Ratio | 24.07 | N/A |
| Price to 5YR AVG FCF Ratio | 24.25 | N/A |
Profitability (70%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 11.69% | N/A |
| ROE (TTM) | 26.23% | N/A |
| Net Profit Margin (TTM) | 9.14% | N/A |
| ROIC 5YR AVG | 24.62% | N/A |
Growth (80%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 19.00% | 18.21% | 11.44% |
| Revenue | 3.83% | 12.96% | 8.08% |
| Net Income | 18.28% | 17.60% | 10.85% |
| Cash Flow | 48.73% | 5.45% | 21.07% |
Health (63%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.81 | N/A |
| Quick Ratio (TTM) | 0.74 | N/A |
| D/E Ratio (TTM) | 0.65 | N/A |
| Interest Coverage (TTM) | 8.50 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 5.08 | N/A |
| LTL to 5YR AVG FCF | 2.99 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.56% | N/A |